Whoop is reportedly replacing defective MG trackers
Users of Whoop's fitness trackers have been reporting that their Whoop MG fitness trackers are turning unresponsive, in some cases within under an hour of setting them up. Now, the company is apparently replacing the trackers, in some cases before the users even ask, TechIssuesToday reports.
Launched alongside the Whoop 5.0 earlier this month, the Whoop MG (which stands for 'Medical Grade') comes with EKG capabilities and blood pressure insights and requires a premium Whoop Life subscription that's $359 per year. Users started reporting issues with the tracker almost immediately.
On May 11th, a user reported in the Whoop community forum that their MG 'stopped working overnight after working for 8 hours. No green light, no bluelight nothing. It won't now pair with the app.' Others replied to say the tracker failed even sooner for them, with one person reporting that it went inert after just half an hour of use. Some also report that their 5.0 has failed.
The company appears to be trying to rectify the situation by sending out replacement units, sometimes without users even asking for one, as the Reddit user who posted the screenshot above wrote further down in the thread. The same goes for a user who posted two days ago to say they got the same notification despite having not noticed any problems with their MG. Some in that thread even write that the company replaced their MGs without ever telling them it would be doing so.
It's already been a troubled launch for Whoop. Earlier this month, some users were outraged when Whoop said they would need to add another 12 months onto their memberships to avoid the upgrade fee for the Whoop 5.0. Previously, users only needed to have 6 months left on their subscription to get a Whoop 4.0. The company soon walked its new terms back, posting on Reddit that those who had at least 12 months left would be eligible for an upgrade.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
26 minutes ago
- Yahoo
OpenAI scrubs news of Jony Ive deal amid trademark dispute
OpenAI has removed news of its deal with Jony Ive's io from its website. The takedown comes amid a trademark dispute filed by iyO, an AI hardware startup. OpenAI said it doesn't agree with the complaint and is "reviewing our options." Turns out "i" and "o" make for a popular combination of vowels in the tech industry. Sam Altman's OpenAI launched a very public partnership with io, the company owned by famed Apple designer Jony Ive, in May. The announcement included a splashy video and photos of the two of them looking like old friends. On Sunday, however, OpenAI scrubbed any mention of that partnership from its website and social media. That's because iyO, a startup spun out of Google's moonshot factory, X, and which sounds like io, is suing OpenAI, io, Altman, and Ive for trademark infringement. iyO's latest product, iyO ONE, is an "ear-worn device that uses specialized microphones and bone-conducted sound to control audio-based applications with nothing more than the user's voice," according to the suit iyO filed on June 9. The partnership between OpenAI and io, meanwhile, is rumored to be working on a similarly screen-less, voice-activated AI device. According to its deal with OpenAI, Ive's firm will lead creative direction and design at OpenAI, focusing on developing a new slate of consumer devices. When the deal was announced, neither party shared specific details about future products. However, Altman said the partnership would shape the "future of AI." iyO approached OpenAI earlier this year about a potential collaboration and funding. OpenAI declined that offer, however, and says it is now fighting the trademark lawsuit. "We don't agree with the complaint and are reviewing our options," OpenAI told Business Insider. Read the original article on Business Insider
Yahoo
30 minutes ago
- Yahoo
Dow Jones Futures Open Lower, Oil Climbs After U.S. Bombs Iran Nuclear Sites; Tesla Launches Robotaxi Service
Dow Jones futures traded lower after President Trump announced the U.S. bombed Iran nuclear sites. The Tesla launched its robotaxi service.
Forbes
34 minutes ago
- Forbes
Price Controls On Doctors Are Costing Patients Dearly
Market Manipulation Just like the December 2024 continuing resolution, the current budget reconciliation bill fails to address the problem of Medicare reimbursing physicians at below market rates. Without a fix, the inevitable consequences will be worsening doctor shortages, declining healthcare quality, higher overall healthcare spending, and the accelerated loss of independent practices. Of course, how do we know that Medicare's payments to doctors are below their economic value? To start, Medicare's reimbursement rates have declined relative to both the cost of running a medical practice and inflation. Doctors consistently report that they lose money treating Medicare patients. A survey of doctors found that Medicare's low reimbursement rates (68%) are a primary threat to independent practices. As for inflation, it has grown 34.5% overall since January 2016 while the prices received by doctors have grown less than half as much - just 15.1%. This is not due to demand for healthcare declining – remember the huge number of aging Baby Boomers seeking health care – or a huge surge in the number of qualified doctors serving patients. In fact, the level of doctors serving patients today - 25.4 active physicians per 10,000 residents - is down from 2019 and has fallen back to 2009 levels. The problem is government setting prices at below market levels. And setting prices below market rates cause adverse consequences to our health, such as fewer doctors available to serve patients. This creates serious health risks for patients including longer wait times for appointments, less access to specialty care, shorter doctor visits, larger numbers of medical errors, and more misdiagnoses or missed diagnoses. These risks are more acute for people living in rural areas, who have a higher chance of living in areas deemed 'medical deserts' or regions that lack sufficient access to pharmacies, primary care providers, and hospitals. Medicare's uneconomical reimbursement system is also changing how patient care is delivered. For example, under the current reimbursement system, Medicare compensates hospitals more than independent physician offices for performing the same service. This incentivizes independent practices to merge with hospitals. Consolidating lower-cost physician practices into higher-cost hospital systems is driving up overall healthcare costs for patients and taxpayers and is reducing patient choice. Congress has acknowledged that there are serious consequences from government price controls, enacting legislation to raise provider payments by 2.9% for most of 2024. But these payments went back down on January 1, and the problem continues to plague the healthcare system. Fixing Medicare's flawed reimbursement policy should be a top priority for Congress. The more efficient reform comprehensively addresses Medicare's broader deficiencies by turning Medicare into a cash-based benefit system that funds health savings accounts (HSAs) for seniors. This direct payment option allows beneficiaries to receive their Medicare benefits in the same manner that they receive their Social Security benefits. At current spending levels, Medicare could give each beneficiary $15,150 annually to cover their insurance and healthcare costs. Under this system, patients and physicians, not bureaucrats, would take change and prices would reflect value. Providers would have to compete and would be incentivized to find new and better ways to expand value and reducing costs for patients. Fundamental reforms that establish well-functioning healthcare and health insurance markets will take time. Given this, Congress could act more immediately to index government payments to medical inflation and stop paying different reimbursement rates for the same services depending on where care is delivered. With more people aging, taxpayers will be spending more and more for Medicare and Medicaid. Unless Congress acts soon to stop Medicare's underpayment of physicians, it is patients who will ultimately pay the highest price with less access to doctors and specialists and longer wait times for life-saving care.
